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Abstract
Disadvantaged populations are disproportionately affected by multiple chronic conditions (MCCs), yet few stud-
ies examine the prevalence, outcomes, or effectiveness of MCC interventions in minority and socioeconomically 
deprived individuals and populations. An important fi rst step in understanding MCCs, not only in such diverse 
population groups, but also in the general population as a whole, is to broaden the defi nition and scope of MCC 
measurement, to encompass more than the simple additive effect of clinical conditions, and to include a wide 
range of health and health-related aspects that interact and make up the full spectrum of multimorbidity. Only 
with the use of a comprehensive MCC measurement can some of the differences between the disadvantaged 
populations be adequately detected. Better understanding of the disparities in access to high  quality health and 
healthcare for persons with MCCs can help guide policy and practice aimed at the prevention and amelioration 
of the effects of MCCs among disadvantaged groups. Indeed, disparity in MCC populations has been identifi ed 
as a key goal of the U.S. Department of Health and Human Services’ Strategic Framework on MCCs. The aim 
of the present paper is to describe current knowledge on disparities in the population of persons with MCCs and 
to guide efforts for the prevention and management of MCCs in disadvantaged populations.
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Introduction
The high prevalence of multiple chronic conditions 
(MCCs) in general, and especially within disadvan-
taged populations, is widely recognized. Worldwide, 
minority populations and persons from low socio-
economic backgrounds have greater health needs 
[1–5], with demographic, economic, social, and cul-
tural challenges to preventing disease manifestation 
[6], maintaining healthy life styles [7] and accessing 
high-quality healthcare [8–10]. It is also increas-
ingly acknowledged that care for persons with MCCs 
requires a patient goal orientation, focused on max-
imizing the health goals of individual patients with 
unique sets of multiple risks, conditions, and priori-
ties, rather than an individual disease-centric approach 
[11]. Disparities in healthcare, defi ned as the difference 
in treatment or access not justifi ed by the differences 
in health status, sociodemographic attributes, or 
preferences of individuals or populations [12], have 
long been shown to affect outcomes of various dis-
eases. Current research, however, does not provide 
insight into how special circumstances of persons with 
MCCs, especially those from diverse social, economic, 
and cultural backgrounds, affect the manifestation and 
management of MCCs. This paper presents the current 
knowledge and suggests the next steps for advancing 
research and practice aimed at the prevention and 
care of disadvantaged populations with MCCs, with 
special reference to the U.S. Department of Human 
and Health Services’ (HHS) Strategic Framework on 
MCCs.
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Preventing MCCs
A plethora of research exists on the identifi cation of 
risk factors and the prevention of chronic conditions. 
However, few studies specifi cally focus on the preven-
tion of MCCs. Both food insuffi ciency [13] and excess 
caloric consumption [14,15] have been shown to be 
associated with a higher risk of multimorbidity. Addi-
tionally, low levels of physical activity have been linked 
to MCCs [16]. Persons from disadvantaged populations 
are at increased risk of food insuffi ciency, as well as 
obesity and lack of physical activity. Moreover, cluster-
ing of physical and psychosocial determinants within 
disadvantaged populations can catalyze the emergence 
and progression of MCCs. A recent study of a cohort 
of earthquake survivors in Armenia showed that, apart 
from a high body mass index, several psychosocial fac-
tors, including perceived low affordability of healthcare 
services, poor living standards, lower education, stress-
ful life events, and poor social support, were predictors 
of incident multimorbidity [17]. Importantly, the strong 
signifi cant relationship between age and multimorbid-
ity was, in fact, largely attributed to the number of 
stressful life events, suggesting that experiencing such 
stressful events during one’s lifespan might be a greater 
risk factor for incident multimorbidity than the lifespan 
itself.
As many chronic conditions share similar risk factors, 
namely, tobacco use, alcohol abuse, an unhealthy diet, 
and physical inactivity [18], lessons for the prevention 
of MCCs can be drawn from the general literature on 
chronic disease prevention and disparity reduction. A 
major challenge to achieving success in chronic disease 
prevention is that it requires large-scale policy changes 
and investment at the population level. However, once 
implemented, unlike treatment that is often focused on 
a single disease, most of these actions can potentially 
prevent the occurrence of multiple conditions, and 
therefore have very large benefi ts for the health of popu-
lations [19].
Smoking, for example, is one of the most well-
established risk factors for lung and other cancers, 
cardiovascular diseases, obstructive lung disease, and 
many other chronic conditions [20]. Some smoking-
cessation interventions hold the risk of increasing the 
tobacco-use gap between low- and high-income popu-
lations, such as non-subsidized nicotine replacement 
therapy, which is more readily available and affordable 
for high-income populations [21]. Yet, other preventive 
strategies hold promise for disparity reduction. For exam-
ple, interventions, such as bans on smoking in certain 
locations, universally affect a wide range of popu lations, 
or tobacco taxation, which disproportionately affects the 
poorest [22].
Managing MCCs
Managing MCCs requires integration of several self-care 
tasks for complex treatment regimes of potentially inter-
acting conditions [23]. Minority patients, and especially 
those with low health literacy, limited education, and/
or poor linguistic profi ciency, may be especially prone 
to signifi cant barriers to successful management of their 
condition [24], particularly when faced with multiple 
self-care requirements. Managing MCCs also requires 
coordination amongst the various treatment recom-
mendations from multiple providers [25], ensuring that 
appointments are not missed and effectively navigating 
the healthcare system. For persons from disadvantaged 
populations, this may be particularly demanding [26, 
27], due to the multitude of personal, fi nancial, and 
organizational barriers to integrated care.
To date, however, there is little knowledge on how 
the specifi c care management needs of low socioeco-
nomic and minority populations with MCCs can be 
met. Social support, for example, which is generally 
viewed as an important resource for self-care of MCCs 
[23], was not strongly related to self-care behaviors in a 
study of rural Appalachians with MCCs [28]. That study 
showed that patients with MCCs did not rely heavily 
on informal support to help them manage their multiple 
morbidities, preferring to call on their formal providers, 
or on self-reliance. Similarly, interventions in individuals 
with MCCs may have a differential impact in differ-
ent populations. For example, a multisite, prospective, 
randomized, controlled study of diabetes patients with 
multimorbidity in Glasgow, Scotland, showed that edu-
cational interventions that were culturally appropriate 
could improve diabetes knowledge, attitudes and prac-
tice in patients from different ethnic minority groups 
[29]. The intervention was also effective in improving 
knowledge and attitudes towards complications in the 
White control group. However, the differences observed 
between the ethnic minority and White control groups 
were not signifi cant. Similarly, a meta-analysis of patient 
education interventions failed to demonstrate any dif-
ferential impact among different population groups [30]. 
In that study, the interventions were effective in increas-
ing physical activity among adults with diverse (usually 
multiple) chronic illnesses, but they were unrelated to 
gender, age, ethnicity, and socioeconomic distribution 
[30]. Overall, these fi ndings have important implica-
tions for the development of self-management support 
programs in diverse population groups.
A core feature of health systems that has been shown 
to reduce disparities is the provision of primary care 
services [31]. Both primary care supply and attributes: 
fi rst-contact access for each need; person (rather than 
disease) focused care; comprehensive care for most 
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health needs; and coordinated care, have been shown to 
contribute to a more equitable distribution of health in 
populations, a fi nding that holds in both cross-national 
and within-national studies [31]. These same attrib-
utes are also connected to better care for patients with 
MCCs. MCC patients can signifi cantly benefi t from 
fi rst-contact access, as their problems are often non-
differentiated. Furthermore, person-focused care can 
help lead to more informed decisions about the patient’s 
priorities. Importantly, coordination of the care by 
multiple providers and services with comprehensive 
integration is imperative [32]. However, further research 
is needed in order to delineate the specifi c pathways by 
which primary care achieves disparity reduction within 
populations with MCCs.
Strategic framework on MCCs
The strategic framework on MCCs [33] specifi cally 
addresses the need to improve the understanding of the 
roles of disparities in persons and populations with MCCs, 
calling for research that will more clearly elucidate differ-
ences between, and opportunities for, intervention among 
various population groups, and using research to leverage 
disparity reduction programs. As indicated by Parkeh and 
Goodman in this issue [34], the HHS’s principal research 
effort on disparities in MCC populations is a study that 
aims to describe data systems and data sets that can be ana-
lyzed to better improve understanding of, and approaches 
to, addressing disparities in MCC populations. This effort 
focuses on describing MCC combinations that are most 
important for targeting interventions.
While there is little knowledge on how co-occurring 
chronic diseases are distributed across diverse population 
groups, current research points to several MCC com-
binations that are prevalent in low socioeconomic and 
minority populations. A recent Scottish study on the dis-
tribution of multimorbidity showed a clear link between 
socioeconomic deprivation and multimorbidity, par-
ticularly multimorbidity that included combinations of 
mental and physical health disorders but not combina-
tions of physical illnesses alone [2]: the prevalence of 
both a mental and physical health disorder increased 
gradually with every income deprivation decile (from 
5.9% in the most affl uent group to 11.0% in the least 
affl uent group), while the prevalence of co-occurring 
physical illnesses was similar across most income dep-
rivation deciles. Moreover, that study showed that the 
combinations of chronic obstructive pulmonary dis-
ease, coronary heart disease, diabetes, or cancer with 
each other, or with stroke, painful conditions, depres-
sion or anxiety, were more prevalent in persons living in 
deprived versus affl uent areas. A reverse income gradient 
was seen for combinations of the above four index con-
ditions and dementia or atrial fi brillation.
Several studies have examined specifi c combinations 
of chronic conditions in ethnic minority popula-
tions [35–37]. For example, a study of the incidence, 
prevalence, and mortality of heart attack in Mexican-
American elders showed that Mexican patients are more 
likely to be male, older, and have co-occurring diabetes 
mellitus, hypertension, and stroke [35]. Other studies 
showed that ethnic minority patients with diabetes are 
more likely to have multiple cerbrovascular [36] and 
cardiovascular [37] risk factors over time compared to 
non-Hispanic Whites. It should be noted, however, that 
as with any study on combinations of health conditions, 
the ability to detect differences in disease combinations 
is contingent upon the number and types of conditions 
assessed and the classifi cation of each study as to which 
disease constitutes the index condition and how comor-
bidities are defi ned.
Research, however, needs to move quickly beyond 
description of existing gaps. Addressing disparities in 
MCCs warrants a wide-ranging consideration that 
encompasses the various social determinants and their 
interactions with MCCs. Several characteristics distin-
guish the study and implementation of interventions for 
MCCs in socially disadvantaged populations. For exam-
ple, age is a major factor. To date, most studies on MCCs 
focus on the elderly. While MCCs are more prevalent 
in older adults [2,38,39], socially disadvantaged groups 
are, on average, younger, and, disproportional to their 
peers, suffer from poorer health [6]. A recent study on 
the association between MCCs and health-related qual-
ity of life (HRQoL) and its variation by socioeconomic 
deprivation has found that MCCs have a substantial neg-
ative impact on HRQoL, which is most severe in areas 
of deprivation, especially in younger adults [40]. The 
fact that young adults are markedly predisposed to the 
negative effects of deprivation on MCCs is an essential 
area for further investigation, particularly as most current 
research on MCCs is still focused on older adults [41–43].
Interventions for older persons with MCCs may not be 
directly transferable to younger, working-age adults. The 
non-elderly not only have different types of co-occurring 
conditions than older adults [44], but also different types 
of social support systems and responsibilities. These chal-
lenges can affect patients’ abilities to perform self-care 
tasks and effectively manage their MCCs [23], especially 
when adding social and cultural factors, such as unem-
ployment or inadequate language profi ciency [45].
Building a strategic framework to improve the health 
and quality of life of persons with MCCs requires a special 
focus on disparity reduction that is also due to structural 
factors. Importantly, where categorical benefi ts and the 
type of insurance are generally age-dependent (as is 
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the case in the USA), fostering healthcare changes to 
improve the health of individuals with MCCs requires a 
concentrated effort in directing care for non-Medicare-
eligible individuals – namely, the socially disadvantaged, 
younger adults with MCCs. Recent national (USA) and 
international efforts can help guide these paths [46,47].
Another important contributor to the need for a spe-
cial disparity-reduction focus has to do with the nature 
of program implementation. Research shows that uni-
versally applied quality improvement (QI) efforts do not 
necessarily reduce disparities [48,49], as socially and eco-
nomically stable or advantaged populations tend to absorb 
the interventions earlier, and thus, potentially increas-
ing the care-quality gap. An organization-wide MCC 
disparity-reduction strategy (including interventions for 
diabetes, hypertension, and hyperlipidemia control and 
cancer screening) implemented within Israel’s largest 
non-profi t health plan (Clalit Health Services) provides 
an example of how to overcome such an “inverse QI 
law.” Results of implementation of the Clalit dispar-
ity-reduction program show that, though historically, 
improvement in average quality scores was consistently 
achieved [50], only after specifi cally directing tailored 
efforts towards low socioeconomic and minority clin-
ics, did the gaps in health and healthcare subside [51]. 
Similarly, embarking on any MCC improvement effort, 
without initially considering the implication for mar-
ginalized population groups and the need to provide 
customized solutions to minority populations, those of 
low socioeconomic position or anyone otherwise disad-
vantaged, can potentially increase disparities in MCCs.
Next steps in MCC disparity research
While it is important to note that a large share of the 
burden of MCC lies within socially and economically 
stable populations, several of the initiatives that stem 
from the MCC framework have important implications 
for future MCC disparity research and practice:
1. As described by Parkeh and Goodman [34], the 
FDA is currently examining the question of whether 
individuals with MCCs are being excluded from con-
trolled clinical trials. To complement this initiative, 
within a disparity-reduction MCC framework, it is 
also important to ensure that marginalized groups 
with MCCs are adequately represented [52].
2. To capture disparities between and within popula-
tions, there is a need to broaden the defi nition and 
scope of MCC measurement. The MCC framework 
defi nes MCCs as two or more concurrent chronic 
conditions. Defi ning MCCs as a sum of chronic 
conditions may have signifi cant implications for the 
identifi cation of the extent of differences between 
populations [10], as well as the manifestation and 
outcomes of MCCs in various population groups. 
Measures that simply sum chronic diseases may fail 
to capture the burden associated with multimor-
bidity [53]. Fried and colleagues, for example, have 
shown that a substantial amount of the contribution 
of disease to disability may derive from the interac-
tions of specifi c chronic diseases, and is well beyond 
the additive effects of several diseases independently 
[54]. While such a broad defi nition of various types 
of interacting conditions, rather than a count of 
chronic conditions, is benefi cial for any classifi cation 
of MCCs, for minority or otherwise marginalized 
populations, a broad defi nition that captures not only 
predetermined diagnosed diseases but also acute con-
ditions and general symptoms may be particularly 
important as disparities in diagnoses exist [55]. Such 
gaps may result in under-identifi cation of chronic 
conditions and a need to capture patient complexity 
based on classifi cation of a wider range of preiden-
tifi ed conditions (i.e. symptoms or risk factors) and 
their interactions [56,57].
3. Most MCC literature to date is descriptive or epidemio-
logical in nature [58]. Few studies describe interventions 
for the treatment of persons with MCCs [59]. Of this 
limited evidence base, there is minimal consideration 
of the impact of socioeconomic deprivation; none of 
the studies that were included in the above-mentioned 
review considered the possibility of a differential effect 
of interventions in various socioeconomic groups. 
Future research should aim to assess MCC interven-
tions in a wide range of population groups, especially 
considering younger, working-age adults.
4. Healthcare systems and organizations that aim to 
reduce disparities in prevention and treatment of 
MCCs should adopt a comprehensive approach, 
building on both the MCC strategic framework 
[33] and on well-established principles of dispar-
ity reduction. Specifi cally, systems for documenting 
population characteristics, such as socioeconomic 
status, education level, and ethnicity should be estab-
lished [26]. Such patient and population classifi cation 
can aid in directing tailored prevention and treatment 
strategies to those who need them the most. Interven-
tions should be developed based on the understanding 
that some prevention and treatment approaches can 
potentially increase disparities within populations 
with MCCs, particularly as organizational, fi nancial, 
or health literacy barriers can impede adoption by 
disadvantaged populations. Healthcare services that 
provide a strong primary care foundation can signifi -
cantly improve MCC prevention and management as 
well as reduce disparities.
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Conclusions
A strategy that focuses on improving the health and 
healthcare of persons with MCCs is more equitable than 
a single-disease approach. The priority areas identifi ed 
by the HHS Strategic Framework – geared towards the 
general population with MCCs – also have important 
implications for reducing disparities in MCCs within 
populations. Focusing on the complete spectrum of 
morbidity (rather than individual conditions), in which 
multiple illnesses and health-related needs interact, can 
more accurately depict the much greater impact of ill-
ness among the socially disadvantaged [60]. Meeting the 
specifi c objectives of the MCC strategic framework [33], 
of addressing disparities in MCC populations, should 
be considered within a broad context of measurement, 
infrastructure, and intervention. This paper suggests that 
such an effort should include better documentation of 
sociocultural characteristics of populations and improved 
understanding of the role and inter-relatedness of risk 
factors within distinct population groups; establish-
ment of a strong primary care organization of services; 
and development of prevention and care-management 
interventions that are tailored to the intricate needs of 
populations that experience organizational, economic, 
and cultural barriers to effective healthcare.
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